Effects of Anesthesia on Postoperative Recurrence and Metastasis of Malignant Tumors

References

• Kim R. Effects of surgery and anesthetic choice on immunosuppression and cancer recurrence. J Transl Med. 2018;16(1):8. doi:10.1186/s12967-018-1389-729347949
   PubMed Web of Science ®Google Scholar
• Wang W, Xiao J, Shen S, Wang S, Chen M, Hu Y. Emerging effect of anesthesia on post-operative tumor recurrence and metastasis. J Int Med Res. 2019;47(8):3550–3558. doi:10.1177/030006051986145531296069
   PubMed Web of Science ®Google Scholar
• Sessler DI, Pei L, Huang Y, et al. Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial. Lancet. 2019;394(10211):1807–1815. doi:10.1016/S0140-6736(19)32313-X31645288
   PubMed Web of Science ®Google Scholar
• Dong J, Zeng M, Ji N, et al. Impact of anesthesia on long-term outcomes in patients with supratentorial high-grade glioma undergoing tumor resection: a retrospective cohort study. J Neurosurg Anesthesiol. 2020;32(3):227–233. doi:10.1097/ANA.000000000000058830807485
   PubMed Web of Science ®Google Scholar
• Anderson SL, Duke-Novakovski T, Singh B. The immune response to anesthesia: part 2 sedatives, opioids, and injectable anesthetic agents. Vet Anaesth Analg. 2014;41(6):553–566. doi:10.1111/vaa.1219124962601
   PubMed Web of Science ®Google Scholar
• Moradkhani MR, Karimi A. Role of drug anesthesia and cancer. Drug Res (Stuttg). 2018;68(3):125–131. doi:10.1055/s-0043-11907129161749
   PubMed Web of Science ®Google Scholar
• Byrne K, Levins KJ, Buggy DJ. Can anesthetic-analgesic technique during primary cancer surgery affect recurrence or metastasis? Can J Anaesth. 2016;63(2):184–192. doi:10.1007/s12630-015-0523-826497721
   PubMed Web of Science ®Google Scholar
• Dubowitz JA, Sloan EK, Riedel BJ. Implicating anaesthesia and the perioperative period in cancer recurrence and metastasis. Clin Exp Metastasis. 2018;35(4):347–358. doi:10.1007/s10585-017-9862-x28894976
   PubMed Web of Science ®Google Scholar
• Vahabi S, Eatemadi A. Effects of anesthetic and analgesic techniques on cancer metastasis. Biomed Pharmacother. 2017;87:1–7. doi:10.1016/j.biopha.2016.12.07328040593
   PubMed Web of Science ®Google Scholar
• Longhini F, Bruni A, Garofalo E, et al. Anesthetic strategies in oncological surgery: not only a simple sleep, but also impact on immunosuppression and cancer recurrence. Cancer Manag Res. 2020;12:931–940. doi:10.2147/CMAR.S23722432104075
   PubMed Web of Science ®Google Scholar
• Lee EK, Ahn HJ, Zo JI, Kim K, Jung DM, Park JH. Paravertebral block does not reduce cancer recurrence, but is related to higher overall survival in lung cancer surgery: a retrospective cohort study. Anesth Analg. 2017;125(4):1322–1328. doi:10.1213/ANE.000000000000234228857802
   PubMed Web of Science ®Google Scholar
• Fodale V, D’Arrigo MG, Triolo S, Mondello S, La Torre D. Anesthetic techniques and cancer recurrence after surgery. ScientificWorldJournal. 2014;2014:328513. doi:10.1155/2014/32851324683330
   PubMedGoogle Scholar
• Liu X, Ma M, Huang H, Wang Y. Effect of perioperative blood transfusion on prognosis of patients with gastric cancer: a retrospective analysis of a single center database. BMC Cancer. 2018;18(1):649. doi:10.1186/s12885-018-4574-429890957
   PubMedGoogle Scholar
• Kaye AD, Patel N, Bueno FR, et al. Effect of opiates, anesthetic techniques, and other perioperative factors on surgical cancer patients. Ochsner J. 2014;14(2):216–228.24940132
   PubMedGoogle Scholar
• Yap A, Lopez-Olivo MA, Dubowitz J, Hiller J, Riedel B. Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia. Can J Anaesth. 2019;66(5):546–561. doi:10.1007/s12630-019-01330-x30834506
   PubMed Web of Science ®Google Scholar
• Jin Z, Li R, Liu J, Lin J. Long-term prognosis after cancer surgery with inhalational anesthesia and total intravenous anesthesia: a systematic review and meta-analysis. Int J Physiol Pathophysiol Pharmacol. 2019;11(3):83–94.31333811
   PubMedGoogle Scholar
• Li R, Liu H, Dilger JP, Lin J. Effect of Propofol on breast Cancer cell, the immune system, and patient outcome. BMC Anesthesiol. 2018;18(1):77. doi:10.1186/s12871-018-0543-329945542
   PubMedGoogle Scholar
• Jiang S, Liu Y, Huang L, Zhang F, Kang R. Effects of propofol on cancer development and chemotherapy: potential mechanisms. Eur J Pharmacol. 2018;831:46–51. doi:10.1016/j.ejphar.2018.04.00929654781
   PubMed Web of Science ®Google Scholar
• Sahinovic MM, Struys M, Absalom AR. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet. 2018;57(12):1539–1558. doi:10.1007/s40262-018-0672-330019172
   PubMed Web of Science ®Google Scholar
• Weir CJ, Mitchell SJ, Lambert JJ. Role of GABAA receptor subtypes in the behavioural effects of intravenous general anaesthetics. Br J Anaesth. 2017;119(suppl_1):i167–i175. doi:10.1093/bja/aex36929161398
   PubMedGoogle Scholar
• Lai HC, Lee MS, Lin C, et al. Propofol-based total intravenous anaesthesia is associated with better survival than desflurane anaesthesia in hepatectomy for hepatocellular carcinoma: a retrospective cohort study. Br J Anaesth. 2019;123(2):151–160. doi:10.1016/j.bja.2019.04.05731171343
   PubMed Web of Science ®Google Scholar
• Lai HC, Lee MS, Lin KT, et al. Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in robot-assisted radical prostatectomy. PLoS One. 2020;15(3):e0230290. doi:10.1371/journal.pone.023029032182262
   PubMed Web of Science ®Google Scholar
• Guerrero Orriach JL, Raigon Ponferrada A, Malo Manso A, et al. Anesthesia in combination with propofol increases disease-free survival in bladder cancer patients who undergo radical tumor cystectomy as compared to inhalational anesthetics and opiate-based analgesia. Oncology. 2020;98(3):161–167. doi:10.1159/00050480731962315
   PubMed Web of Science ®Google Scholar
• Lai HC, Lee MS, Liu YT, et al. Propofol-based intravenous anesthesia is associated with better survival than desflurane anesthesia in pancreatic cancer surgery. PLoS One. 2020;15(5):e0233598. doi:10.1371/journal.pone.023359832437450
   PubMed Web of Science ®Google Scholar
• Lai HC, Lee MS, Lin KT, et al. Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in intrahepatic cholangiocarcinoma surgery. Medicine (Baltimore). 2019;98(51):e18472. doi:10.1097/MD.000000000001847231861027
   PubMed Web of Science ®Google Scholar
• Oh TK, Kim HH, Jeon YT. Retrospective analysis of 1-year mortality after gastric cancer surgery: total intravenous anesthesia versus volatile anesthesia. Acta Anaesthesiol Scand. 2019;63(9):1169–1177. doi:10.1111/aas.1341431180151
   PubMed Web of Science ®Google Scholar
• Schaefer MS, Raub D, Xu X, et al. Association between propofol dose and 1-year mortality in patients with or without a diagnosis of solid cancer. Br J Anaesth. 2020;124(3):271–280. doi:10.1016/j.bja.2019.11.02831902588
   PubMed Web of Science ®Google Scholar
• Huang YH, Lee MS, Lou YS, et al. Propofol-based total intravenous anesthesia did not improve survival compared to desflurane anesthesia in breast cancer surgery. PLoS One. 2019;14(11):e0224728. doi:10.1371/journal.pone.022472831697743
   PubMed Web of Science ®Google Scholar
• Enlund M, Berglund A, Ahlstrand R, et al. Survival after primary breast cancer surgery following propofol or sevoflurane general anesthesia-a retrospective, multicenter, database analysis of 6305 Swedish patients. Acta Anaesthesiol Scand. 2020;64(8):1048–1054. doi:10.1111/aas.1364432415980
   PubMed Web of Science ®Google Scholar
• Cata JP, Forget P. Paravertebral block with propofol anaesthesia does not improve survival compared with sevoflurane anaesthesia for breast cancer surgery: independent discussion of a randomised controlled trial. Br J Anaesth. 2020;124(1):19–24. doi:10.1016/j.bja.2019.09.03931727343
   PubMed Web of Science ®Google Scholar
• Wang J, Cheng CS, Lu Y, et al. Novel findings of anti-cancer property of propofol. Anticancer Agents Med Chem. 2018;18(2):156–165. doi:10.2174/187152061766617091212032728901262
   PubMed Web of Science ®Google Scholar
• Farooqi AA, Adylova A, Sabitaliyevich UY, Attar R, Sohail MI, Yilmaz S. Recent updates on true potential of an anesthetic agent as a regulator of cell signaling pathways and non-coding RNAs in different cancers: focusing on the brighter side of propofol. Gene. 2020;737:144452. doi:10.1016/j.gene.2020.14445232044408
   PubMed Web of Science ®Google Scholar
• Deng F, Ouyang M, Wang X, et al. Differential role of intravenous anesthetics in colorectal cancer progression: implications for clinical application. Oncotarget. 2016;7(47):77087–77095. doi:10.18632/oncotarget.1280027780923
   PubMedGoogle Scholar
• Xu YB, Jiang W, Zhao FR, et al. Propofol suppresses invasion and induces apoptosis of osteosarcoma cell in vitro via downregulation of TGF-β1 expression. Eur Rev Med Pharmacol Sci. 2016;20(7):1430–1435.27097968
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhang J, Hong G, Quan J, Zhang L, Yu M. Propofol inhibits growth and invasion of pancreatic cancer cells through regulation of the miR-21/Slug signaling pathway. Am J Transl Res. 2016;8(10):4120–4133.27829997
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang N, Zhou S, Ye W, Jing G, Zhang M. Propofol induces proliferation and invasion of gallbladder cancer cells through activation of Nrf2. J Exp Clin Cancer Res. 2012;31(1):66. doi:10.1186/1756-9966-31-6622901367
   PubMedGoogle Scholar
• Singh V, Gillespie TW, Harvey RD. Intranasal ketamine and its potential role in cancer-related pain. Pharmacotherapy. 2018;38(3):390–401. doi:10.1002/phar.209029396996
   PubMed Web of Science ®Google Scholar
• Visser E, Schug SA. The role of ketamine in pain management. Biomed Pharmacother. 2006;60(7):341–348. doi:10.1016/j.biopha.2006.06.02116854557
   PubMed Web of Science ®Google Scholar
• Quibell R, Fallon M, Mihalyo M, Twycross R, Wilcock A. Ketamine. J Pain Symptom Manage. 2015;50(2):268–278. doi:10.1016/j.jpainsymman.2015.06.00226096492
   PubMed Web of Science ®Google Scholar
• Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg. 2003;97(5):1331–1339. doi:10.1213/01.ANE.0000082995.44040.0714570648
   PubMed Web of Science ®Google Scholar
• He H, Chen J, Xie WP, et al. Ketamine used as an acesodyne in human breast cancer therapy causes an undesirable side effect, upregulating anti-apoptosis protein Bcl-2 expression. Genet Mol Res. 2013;12(2):1907–1915. doi:10.4238/2013.January.4.723315866
   PubMed Web of Science ®Google Scholar
• Malsy M, Gebhardt K, Gruber M, Wiese C, Graf B, Bundscherer A. Effects of ketamine, s-ketamine, and MK 801 on proliferation, apoptosis, and necrosis in pancreatic cancer cells. BMC Anesthesiol. 2015;15:111. doi:10.1186/s12871-015-0076-y26219286
   PubMed Web of Science ®Google Scholar
• Amaram-Davila J, Davis M, Reddy A. Opioids and cancer mortality. Curr Treat Options Oncol. 2020;21(3):22. doi:10.1007/s11864-020-0713-732095929
   PubMed Web of Science ®Google Scholar
• Wong SS, Cheung CW. Optimization of opioid utility in cancer pain populations. Ann Palliat Med. 2020;9(2):558–570. doi:10.21037/apm.2020.03.0432233627
   PubMed Web of Science ®Google Scholar
• Cruickshank M, Henderson L, MacLennan G, et al. Alpha-2 agonists for sedation of mechanically ventilated adults in intensive care units: a systematic review. Health Technol Assess. 2016;20(25):v–117. doi:10.3310/hta20250
   PubMed Web of Science ®Google Scholar
• Levins KJ, Prendeville S, Conlon S, Buggy DJ. The effect of anesthetic technique on µ-opioid receptor expression and immune cell infiltration in breast cancer. J Anesth. 2018;32(6):792–796. doi:10.1007/s00540-018-2554-030229370
   PubMed Web of Science ®Google Scholar
• Connolly C, Buggy DJ. Opioids and tumour metastasis: does the choice of the anesthetic-analgesic technique influence outcome after cancer surgery? Curr Opin Anaesthesiol. 2016;29(4):468–474. doi:10.1097/ACO.000000000000036027214644
   PubMed Web of Science ®Google Scholar
• Singleton PA, Lingen MW, Fekete MJ, Garcia JG, Moss J. Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation. Microvasc Res. 2006;72(1–2):3–11. doi:10.1016/j.mvr.2006.04.00416820176
   PubMed Web of Science ®Google Scholar
• Yamamizu K, Furuta S, Hamada Y, et al. к Opioids inhibit tumor angiogenesis by suppressing VEGF signaling. Sci Rep. 2013;3:3213. doi:10.1038/srep03213
   PubMed Web of Science ®Google Scholar
• Chong D, Shao L, Yang Y, Wang R, Yang C, Zhang B. Correlations of cancer pain degree with levels of β-EP, CGRP and PGE2 and the effects of oxycontin on them. J BUON. 2018;23(5):1552–1557.30570885
   PubMed Web of Science ®Google Scholar
• Farooqui M, Li Y, Rogers T, et al. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer. 2007;97(11):1523–1531. doi:10.1038/sj.bjc.660405717971769
   PubMed Web of Science ®Google Scholar
• Schoos A, Gabriel C, Knab VM, Fux DA. Activation of HIF-1α by δ-opioid receptors induces COX-2 expression in breast cancer cells and leads to paracrine activation of vascular endothelial cells. J Pharmacol Exp Ther. 2019;370(3):480–489. doi:10.1124/jpet.119.25750131300611
   PubMed Web of Science ®Google Scholar
• Tuerxun H, Cui J. The dual effect of morphine on tumor development. Clin Transl Oncol. 2019;21(6):695–701. doi:10.1007/s12094-018-1974-530470993
   PubMed Web of Science ®Google Scholar
• Dupoiron D. Intrathecal therapy for pain in cancer patients. Curr Opin Support Palliat Care. 2019;13(2):75–80. doi:10.1097/SPC.000000000000042730896454
   PubMed Web of Science ®Google Scholar
• Koodie L, Yuan H, Pumper JA, et al. Morphine inhibits migration of tumor-infiltrating leukocytes and suppresses angiogenesis associated with tumor growth in mice. Am J Pathol. 2014;184(4):1073–1084. doi:10.1016/j.ajpath.2013.12.01924495739
   PubMed Web of Science ®Google Scholar
• Kim MH, Oh JE, Park S, et al. Tramadol use is associated with enhanced postoperative outcomes in breast cancer patients: a retrospective clinical study with in vitro confirmation. Br J Anaesth. 2019;123(6):865–876. doi:10.1016/j.bja.2019.09.00431591020
   PubMed Web of Science ®Google Scholar
• Feng Z, Lu X, Gan L, Zhang Q, Lin L. Xanthones, a promising anti-inflammatory scaffold: structure, activity, and drug likeness analysis. Molecules. 2020;25(3):598. doi:10.3390/molecules25030598
   PubMed Web of Science ®Google Scholar
• Zappavigna S, Cossu AM, Grimaldi A, et al. Anti-inflammatory drugs as anticancer agents. Int J Mol Sci. 2020;21(7):2605. doi:10.3390/ijms21072605
   PubMed Web of Science ®Google Scholar
• Ye Y, Wang X, Jeschke U, von Schönfeldt V. COX-2-PGE(2)-EPs in gynecological cancers. Arch Gynecol Obstet. 2020;301(6):1365–1375. doi:10.1007/s00404-020-05559-632363546
   PubMed Web of Science ®Google Scholar
• Majidi A, Na R, Dixon-Suen S, Jordan SJ, Webb PM. Common medications and survival in women with ovarian cancer: a systematic review and meta-analysis. Gynecol Oncol. 2020;157(3):678–685. doi:10.1016/j.ygyno.2020.03.02832317171
   PubMed Web of Science ®Google Scholar
• Woolbright BL, Pilbeam CC, Taylor JA. Prostaglandin E2 as a therapeutic target in bladder cancer: from basic science to clinical trials. Prostaglandins Other Lipid Mediat. 2020;148:106409. doi:10.1016/j.prostaglandins.2020.10640931931078
   PubMed Web of Science ®Google Scholar
• Choi JE, Villarreal J, Lasala J, et al. Perioperative neutrophil: lymphocyte ratio and postoperative NSAID use as predictors of survival after lung cancer surgery: a retrospective study. Cancer Med. 2015;4(6):825–833. doi:10.1002/cam4.42825756351
   PubMed Web of Science ®Google Scholar
• Wen QP, Miao Z, Wu P, et al. Whole-course application of dexmedetomidine combined with ketorolac in nonnarcotic postoperative analgesia for patients with lung cancer undergoing thoracoscopic surgery: a randomized control trial. Pain Physician. 2020;23(2):E185–E193.32214297
   PubMed Web of Science ®Google Scholar
• Forget P, De Kock M. Perspectives in anaesthesia for cancer surgery. J Cancer Res Clin Oncol. 2014;140(3):353–359. doi:10.1007/s00432-013-1522-124077864
   PubMed Web of Science ®Google Scholar
• Jiao B, Yang C, Huang NN, Yang N, Wei J, Xu H. Relationship between volatile anesthetics and tumor progression: unveiling the mystery. Curr Med Sci. 2018;38(6):962–967. doi:10.1007/s11596-018-1970-630536056
   PubMed Web of Science ®Google Scholar
• Xu Y, Jiang W, Xie S, Xue F, Zhu X. The role of inhaled anesthetics in tumorigenesis and tumor immunity. Cancer Manag Res. 2020;12:1601–1609. doi:10.2147/CMAR.S24428032184663
   PubMed Web of Science ®Google Scholar
• Evans DR, Fowler-Williams C, Ma D. Is volatile anesthesia during cancer surgery likely to increase the metastatic risk? Int Anesthesiol Clin. 2016;54(4):92–107. doi:10.1097/AIA.000000000000011527623130
   PubMedGoogle Scholar
• Mitsui Y, Hou L, Huang X, Odegard KC, Pereira LM, Yuki K. Volatile anesthetic sevoflurane attenuates toll-like receptor 1/2 activation. Anesth Analg. 2020;131(2):631–639. doi:10.1213/ANE.000000000000474132149756
   PubMed Web of Science ®Google Scholar
• de Sousa GC, Cruz FF, Heil LB, et al. Intraoperative immunomodulatory effects of sevoflurane versus total intravenous anesthesia with propofol in bariatric surgery (the OBESITA trial): study protocol for a randomized controlled pilot trial. Trials. 2019;20(1):300. doi:10.1186/s13063-019-3399-z31138279
   PubMedGoogle Scholar
• Liu S, Gu X, Zhu L, et al. Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer. Medicine (Baltimore). 2016;95(49):e5479. doi:10.1097/MD.000000000000547927930529
   PubMed Web of Science ®Google Scholar
• Shi QY, Zhang SJ, Liu L, et al. Sevoflurane promotes the expansion of glioma stem cells through activation of hypoxia-inducible factors in vitro. Br J Anaesth. 2015;114(5):825–830. doi:10.1093/bja/aeu40225492570
   PubMed Web of Science ®Google Scholar
• Hirai T, Konishi Y, Mizuno S, Rui Z, Sun Y, Nishiwaki K. Differential effects of sevoflurane on the growth and apoptosis of human cancer cell lines. J Anesth. 2020;34(1):47–57. doi:10.1007/s00540-019-02701-w31667585
   PubMed Web of Science ®Google Scholar
• Benzonana LL, Perry NJ, Watts HR, et al. Isoflurane, a commonly used volatile anesthetic, enhances renal cancer growth and malignant potential via the hypoxia-inducible factor cellular signaling pathway in vitro. Anesthesiology. 2013;119(3):593–605. doi:10.1097/ALN.0b013e31829e47fd23774231
   PubMed Web of Science ®Google Scholar
• Zhu M, Li M, Zhou Y, et al. Isoflurane enhances the malignant potential of glioblastoma stem cells by promoting their viability, mobility in vitro and migratory capacity in vivo. Br J Anaesth. 2016;116(6):870–877. doi:10.1093/bja/aew12427199319
   PubMed Web of Science ®Google Scholar
• Zhang W, Shao X. Isoflurane promotes non-small cell lung cancer malignancy by activating the Akt-mammalian target of rapamycin (mTOR) signaling pathway. Med Sci Monit. 2016;22:4644–4650. doi:10.12659/MSM.89843427897153
   PubMed Web of Science ®Google Scholar
• Kawaraguchi Y, Horikawa YT, Murphy AN, et al. Volatile anesthetics protect cancer cells against tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via caveolins. Anesthesiology. 2011;115(3):499–508. doi:10.1097/ALN.0b013e3182276d4221862885
   PubMed Web of Science ®Google Scholar
• Sneyd JR. Thiopental to desflurane - an anaesthetic journey. Where are we going next? Br J Anaesth. 2017;119(suppl_1):i44–i52. doi:10.1093/bja/aex32829161390
   PubMedGoogle Scholar
• Iwasaki M, Zhao H, Jaffer T, et al. Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells. Oncotarget. 2016;7(18):26042–26056. doi:10.18632/oncotarget.830427028996
   PubMedGoogle Scholar
• Müller-Edenborn B, Roth-Z’graggen B, Bartnicka K, et al. Volatile anesthetics reduce invasion of colorectal cancer cells through down-regulation of matrix metalloproteinase-9. Anesthesiology. 2012;117(2):293–301. doi:10.1097/ALN.0b013e3182605df122739763
   PubMed Web of Science ®Google Scholar
• Reichle FM, Conzen PF. Halogenated inhalational anaesthetics. Best Pract Res Clin Anaesthesiol. 2003;17(1):29–46. doi:10.1053/bean.2002.026512751547
   PubMedGoogle Scholar
• Woo JH, Baik HJ, Kim CH, et al. Effect of propofol and desflurane on immune cell populations in breast cancer patients: a randomized trial. J Korean Med Sci. 2015;30(10):1503–1508. doi:10.3346/jkms.2015.30.10.150326425050
   PubMed Web of Science ®Google Scholar
• Heavner JE. Local anesthetics. Curr Opin Anaesthesiol. 2007;20(4):336–342. doi:10.1097/ACO.0b013e3281c10a0817620842
   PubMed Web of Science ®Google Scholar
• Liu H, Dilger JP, Lin J. Effects of local anesthetics on cancer cells. Pharmacol Ther. 2020;212:107558. doi:10.1016/j.pharmthera.2020.10755832343985
   PubMed Web of Science ®Google Scholar
• Pérez-González O, Cuéllar-Guzmán LF, Soliz J, Cata JP. Impact of regional anesthesia on recurrence, metastasis, and immune response in breast cancer surgery: a systematic review of the literature. Reg Anesth Pain Med. 2017;42(6):751–756. doi:10.1097/AAP.000000000000066228953508
   PubMed Web of Science ®Google Scholar
• Sen S, Koyyalamudi V, Smith DD, et al. The role of regional anesthesia in the propagation of cancer: a comprehensive review. Best Pract Res Clin Anaesthesiol. 2019;33(4):507–522. doi:10.1016/j.bpa.2019.07.00431791567
   PubMed Web of Science ®Google Scholar
• Sakaguchi M, Kuroda Y, Hirose M. The antiproliferative effect of lidocaine on human tongue cancer cells with inhibition of the activity of epidermal growth factor receptor. Anesth Analg. 2006;102(4):1103–1107. doi:10.1213/01.ane.0000198330.84341.3516551906
   PubMed Web of Science ®Google Scholar
• Siekmann W, Tina E, Von Sydow AK, Gupta A. Effect of lidocaine and ropivacaine on primary (SW480) and metastatic (SW620) colon cancer cell lines. Oncol Lett. 2019;18(1):395–401. doi:10.3892/ol.2019.1033231497075
   PubMed Web of Science ®Google Scholar
• Lirk P, Hollmann MW, Fleischer M, Weber NC, Fiegl H. Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro. Br J Anaesth. 2014;113(Suppl 1):i32–38. doi:10.1093/bja/aeu20124946779
   PubMed Web of Science ®Google Scholar
• Chang YC, Hsu YC, Liu CL, Huang SY, Hu MC, Cheng SP. Local anesthetics induce apoptosis in human thyroid cancer cells through the mitogen-activated protein kinase pathway. PLoS One. 2014;9(2):e89563. doi:10.1371/journal.pone.008956324586874
   PubMed Web of Science ®Google Scholar
• Zanni MP, Mauri-Hellweg D, Brander C, et al. Characterization of lidocaine-specific T cells. J Immunol. 1997;158(3):1139–1148.9013953
   PubMed Web of Science ®Google Scholar
• Chamaraux-Tran TN, Piegeler T. The amide local anesthetic lidocaine in cancer surgery-potential antimetastatic effects and preservation of immune cell function? A narrative review. Front Med (Lausanne). 2017;4:235. doi:10.3389/fmed.2017.0023529326939
   PubMed Web of Science ®Google Scholar
• Azuma Y, Ohura K. Immunological modulation by lidocaine-epinephrine and prilocaine-felypressin on the functions related to natural immunity in neutrophils and macrophages. Curr Drug Targets Immune Endocr Metabol Disord. 2004;4(1):29–36. doi:10.2174/156800804333997415032623
   PubMedGoogle Scholar
• Kim R. Anesthetic technique for cancer surgery: harm or benefit for cancer recurrence? Eur J Surg Oncol. 2018;44(5):557–558. doi:10.1016/j.ejso.2018.02.20729530344
   PubMed Web of Science ®Google Scholar
• Iwasaki M, Edmondson M, Sakamoto A, Ma D. Anesthesia, surgical stress, and “long-term” outcomes. Acta Anaesthesiol Taiwan. 2015;53(3):99–104. doi:10.1016/j.aat.2015.07.00226235899
   PubMedGoogle Scholar
• Tseng KS, Kulkarni S, Humphreys EB, et al. Spinal anesthesia does not impact prostate cancer recurrence in a cohort of men undergoing radical prostatectomy: an observational study. Reg Anesth Pain Med. 2014;39(4):284–288. doi:10.1097/AAP.000000000000010824918335
   PubMed Web of Science ®Google Scholar
• Short TG, Leslie K, Chan MT, Campbell D, Frampton C, Myles P. Rationale and design of the balanced anesthesia study: a prospective randomized clinical trial of two levels of anesthetic depth on patient outcome after major surgery. Anesth Analg. 2015;121(2):357–365. doi:10.1213/ANE.000000000000079725993386
   PubMed Web of Science ®Google Scholar
• Looney M, Doran P, Buggy DJ. Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor β in women undergoing anesthesia and surgery for breast cancer. Anesthesiology. 2010;113(5):1118–1125. doi:10.1097/ALN.0b013e3181f79a6920930611
   PubMed Web of Science ®Google Scholar
• Poeran J, Mazumdar M, Memtsoudis SG. Anesthesia, outcomes, and public health: changing health care while “asleep”. Reg Anesth Pain Med. 2014;39(3):192–194. doi:10.1097/AAP.000000000000008524682083
   PubMed Web of Science ®Google Scholar
• Tai YH, Wu HL, Mandell MS, Tsou MY, Chang KY. The association of allogeneic blood transfusion and the recurrence of hepatic cancer after surgical resection. Anaesthesia. 2020;75(4):464–471. doi:10.1111/anae.1486231573678
   PubMed Web of Science ®Google Scholar
• Le-Wendling L, Nin O, Capdevila X. Cancer recurrence and regional anesthesia: the theories, the data, and the future in outcomes. Pain Med. 2016;17(4):756–775. doi:10.1111/pme.1289326441010
   PubMed Web of Science ®Google Scholar
• Neri D, Sondel PM. Immunocytokines for cancer treatment: past, present and future. Curr Opin Immunol. 2016;40:96–102. doi:10.1016/j.coi.2016.03.00627060634
   PubMed Web of Science ®Google Scholar
• Budhwani M, Mazzieri R, Dolcetti R. Plasticity of type I interferon-mediated responses in cancer therapy: from anti-tumor immunity to resistance. Front Oncol. 2018;8:322. doi:10.3389/fonc.2018.0032230186768
   PubMed Web of Science ®Google Scholar
• Lewis AL, Chaft J, Girotra M, Fischer GW. Immune checkpoint inhibitors: a narrative review of considerations for the anaesthesiologist. Br J Anaesth. 2020;124(3):251–260. doi:10.1016/j.bja.2019.11.03432007241
   PubMed Web of Science ®Google Scholar
• Lusty AJ, Hosier GW, Koti M, et al. Anesthetic technique and oncological outcomes in urology: a clinical practice review. Urol Oncol. 2019;37(12):845–852. doi:10.1016/j.urolonc.2019.08.00431526652
   PubMed Web of Science ®Google Scholar
• Chowdappa R, Tiwari AR, Arjunan R, Althaf S, Kumar RV, Chunduri S. Perioperative mortality in cancer esophagus-a case control study at a high-volume regional cancer center in South India. Indian J Surg Oncol. 2019;10(1):83–90. doi:10.1007/s13193-018-0825-830948879
   PubMed Web of Science ®Google Scholar
• Cata JP, Gutierrez C, Mehran RJ, et al. Preoperative anemia, blood transfusion, and neutrophil-to-lymphocyte ratio in patients with stage I non-small cell lung cancer. Cancer Cell Microenviron. 2016;3(1):e1116.26949721
   PubMedGoogle Scholar
• Brown KGM, Solomon MJ, Koh CE. Pelvic exenteration surgery: the evolution of radical surgical techniques for advanced and recurrent pelvic malignancy. Dis Colon Rectum. 2017;60(7):745–754. doi:10.1097/DCR.000000000000083928594725
   PubMed Web of Science ®Google Scholar
• Ma QM, Han GS, Li BW, Li XJ, Jiang T. Effectiveness and safety of the use of antifibrinolytic agents in total-knee arthroplasty: a meta-analysis. Medicine (Baltimore). 2020;99(20):e20214. doi:10.1097/MD.000000000002021432443349
   PubMed Web of Science ®Google Scholar
• Soehle M, Dehne H, Hoeft A, Zenker S. Accuracy of the non-invasive Tcore™ temperature monitoring system to measure body core temperature in abdominal surgery. J Clin Monit Comput. 2019. doi:10.1007/s10877-019-00430-9
   PubMed Web of Science ®Google Scholar
• Laitman BM, Ma Y, Hill B, et al. Mild hypothermia is associated with improved outcomes in patients undergoing microvascular head and neck reconstruction. Am J Otolaryngol. 2019;40(3):418–422. doi:10.1016/j.amjoto.2019.03.01030954327
   PubMed Web of Science ®Google Scholar
• Cajigas I, Mahavadi AK, Shah AH, et al. Analysis of intra-operative variables as predictors of 30-day readmission in patients undergoing glioma surgery at a single center. J Neurooncol. 2019;145(3):509–518. doi:10.1007/s11060-019-03317-631642024
   PubMed Web of Science ®Google Scholar
• Aoki Y, Atsumi K, Kora M, Koh N, Yokoyama J. Sugammadex and amino acid infusion can contribute to safe anesthetic management of variegate porphyria. JA Clin Rep. 2018;4(1):49. doi:10.1186/s40981-018-0187-932026031
   PubMedGoogle Scholar
• Du G, Liu Y, Li J, Liu W, Wang Y, Li H. Hypothermic microenvironment plays a key role in tumor immune subversion. Int Immunopharmacol. 2013;17(2):245–253. doi:10.1016/j.intimp.2013.06.01823831011
   PubMed Web of Science ®Google Scholar
• Liang B, Dong T. Effects of propofol on invasion and migration of colon cancer cells and JAK2/STAT3 signaling pathway. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020;45(3):290–296. doi:10.11817/j.issn.1672-7347.2020.18070432386021
   PubMedGoogle Scholar
• Zheng X, Dong L, Zhao S, et al. Propofol affects non-small-cell lung cancer cell biology by regulating the miR-21/PTEN/AKT pathway in vitro and in vivo. Anesth Analg. 2020;Publish Ahead of Print. doi:10.1213/ANE.0000000000004778.
   Web of Science ®Google Scholar
• Wang H, Jiao H, Jiang Z, Chen R. Propofol inhibits migration and induces apoptosis of pancreatic cancer PANC-1 cells through miR-34a-mediated E-cadherin and LOC285194 signals. Bioengineered. 2020;11(1):510–521. doi:10.1080/21655979.2020.175403832303144
   PubMed Web of Science ®Google Scholar
• Liu F, Qiu F, Fu M, Chen H, Wang H. Propofol reduces epithelial to mesenchymal transition, invasion and migration of gastric cancer cells through the microRNA-195-5p/snail axis. Med Sci Monit. 2020;26:e920981. doi:10.12659/MSM.92390932115570
   PubMed Web of Science ®Google Scholar
• Li M, Qu L, Chen F, Zhu X. Propofol upregulates miR-320a and reduces HMGB1 by downregulating ANRIL to inhibit PTC cell malignant behaviors. Pathol Res Pract. 2020;216(4):152856. doi:10.1016/j.prp.2020.15285632098696
   PubMed Web of Science ®Google Scholar
• Yu X, Shi J, Wang X, Zhang F. Propofol affects the growth and metastasis of pancreatic cancer via ADAM8. Pharmacol Rep. 2020;72(2):418–426. doi:10.1007/s43440-019-00015-y32048249
   PubMed Web of Science ®Google Scholar
• Li F, Chen W. Propofol inhibits cell proliferation, migration, and invasion via mir-410-3p/transforming growth factor-β receptor type 2 (TGFBR2) axis in glioma. Med Sci Monit. 2020;26:e919523.31960827
   PubMed Web of Science ®Google Scholar
• Su Z, Liu HL, Qi B, Liu Y. Effects of propofol on proliferation and apoptosis of cardia cancer cells via MAPK/ERK signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(1):428–433. doi:10.26355/eurrev_202001_1994231957857
   PubMed Web of Science ®Google Scholar
• Zhang YF, Li CS, Zhou Y, Lu XH. Effects of propofol on colon cancer metastasis through STAT3/HOTAIR axis by activating WIF-1 and suppressing Wnt pathway. Cancer Med. 2020;9(5):1842–1854. doi:10.1002/cam4.284031953926
   PubMed Web of Science ®Google Scholar
• Zhang YF, Li CS, Zhou Y, Lu XH. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer. Life Sci. 2020;244:117280. doi:10.1016/j.lfs.2020.11728031926239
   PubMed Web of Science ®Google Scholar
• Chu CN, Wu KC, Chung WS, et al. Etomidate suppresses invasion and migration of human A549 lung adenocarcinoma cells. Anticancer Res. 2019;39(1):215–223. doi:10.21873/anticanres.1310030591461
   PubMed Web of Science ®Google Scholar
• Chen HT, Zhou J, Fan YL, et al. Anesthetic agent etiomidate induces apoptosis in N2a brain tumor cell line. Mol Med Rep. 2018;18(3):3137–3142. doi:10.3892/mmr.2018.929830066945
   PubMed Web of Science ®Google Scholar
• Hu J, Duan W, Liu Y. Ketamine inhibits aerobic glycolysis in colorectal cancer cells by blocking the NMDA receptor-CaMK II-c-Myc pathway. Clin Exp Pharmacol Physiol. 2020;47(5):848–856. doi:10.1111/1440-1681.1324831889340
   PubMed Web of Science ®Google Scholar
• Duan W, Hu J, Liu Y. Ketamine inhibits colorectal cancer cells malignant potential via blockage of NMDA receptor. Exp Mol Pathol. 2019;107:171–178. doi:10.1016/j.yexmp.2019.02.00430817910
   PubMed Web of Science ®Google Scholar
• Grandhi RK, Lee S, Abd-Elsayed A. Does opioid use cause angiogenesis and metastasis? Pain Med. 2017;18(1):140–151. doi:10.1093/pm/pnw13227346886
   PubMed Web of Science ®Google Scholar
• Zhang J, Yao N, Tian S. Morphine stimulates migration and growth and alleviates the effects of chemo drugs via AMPK-dependent induction of epithelial-mesenchymal transition in esophageal carcinoma cells. Biol Pharm Bull. 2020;43(5):774–781. doi:10.1248/bpb.b19-0077932378556
   PubMed Web of Science ®Google Scholar
• Cui JH, Jiang WW, Liao YJ, Wang QH, Xu M, Li Y. Effects of oxycodone on immune function in patients undergoing radical resection of rectal cancer under general anesthesia. Medicine (Baltimore). 2017;96(31):e7519. doi:10.1097/MD.000000000000751928767570
   PubMed Web of Science ®Google Scholar
• Gaspani L, Bianchi M, Limiroli E, Panerai AE, Sacerdote P. The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats. J Neuroimmunol. 2002;129(1–2):18–24. doi:10.1016/S0165-5728(02)00165-012161016
   PubMed Web of Science ®Google Scholar
• Wang HW, Wang LY, Jiang L, Tian SM, Zhong TD, Fang XM. Amide-linked local anesthetics induce apoptosis in human non-small cell lung cancer. J Thorac Dis. 2016;8(10):2748–2757. doi:10.21037/jtd.2016.09.6627867550
   PubMed Web of Science ®Google Scholar
• Retsky M, Rogers R, Demicheli R, et al. NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup. Breast Cancer Res Treat. 2012;134(2):881–888. doi:10.1007/s10549-012-2094-522622810
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang Q, Li Z, et al. Naproxen platinum(iv) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo. Dalton Trans. 2020;49(16):5192–5204. doi:10.1039/D0DT00424C32236281
   PubMed Web of Science ®Google Scholar
• Zhang W, Sheng B, Chen S, et al. Sevoflurane enhances proliferation, metastatic potential of cervical cancer cells via the histone deacetylase 6 modulation in vitro. Anesthesiology. 2020;132(6):1469–1481. doi:10.1097/ALN.000000000000312932412720
   PubMed Web of Science ®Google Scholar
• Han XC, Zhang YJ, Dong X, Xing QZ, Li KH, Zhang L. Sevoflurane modulates the cancer stem cell-like properties and mitochondrial membrane potential of glioma via Ca(2+)-dependent CaMKII/JNK cascade. Life Sci. 2020;253:117675. doi:10.1016/j.lfs.2020.11767532360621
   PubMed Web of Science ®Google Scholar
• Kang K, Wang Y. Sevoflurane inhibits proliferation and invasion of human ovarian cancer cells by regulating JNK and p38 MAPK signaling pathway. Drug Des Devel Ther. 2019;13:4451–4460. doi:10.2147/DDDT.S223581
   PubMed Web of Science ®Google Scholar
• Li R, Huang Y, Lin J. Distinct effects of general anesthetics on lung metastasis mediated by IL-6/JAK/STAT3 pathway in mouse models. Nat Commun. 2020;11(1):642. doi:10.1038/s41467-019-14065-632005799
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang B, Wang X, Sheng X, Cui Y. Sevoflurane inhibits the progression of ovarian cancer through down-regulating stanniocalcin 1 (STC1). Cancer Cell Int. 2019;19:339. doi:10.1186/s12935-019-1062-031889892
   PubMed Web of Science ®Google Scholar
• Xue F, Xu Y, Song Y, Zhang W, Li R, Zhu X. The effects of sevoflurane on the progression and cisplatinum sensitivity of cervical cancer cells. Drug Des Devel Ther. 2019;13:3919–3928. doi:10.2147/DDDT.S219788
   PubMed Web of Science ®Google Scholar
• Chen M, Zhou L, Liao Z, et al. Sevoflurane inhibited osteosarcoma cell proliferation and invasion via targeting miR-203/WNT2B/Wnt/β-catenin axis. Cancer Manag Res. 2019;11:9505–9515. doi:10.2147/CMAR.S22591131814757
   PubMed Web of Science ®Google Scholar
• Hu J, Jiao H, Li Q, Li Q. Anesthetic effects of isoflurane and the molecular mechanism underlying isoflurane‑inhibited aggressiveness of hepatic carcinoma. Mol Med Rep. 2018;18(1):184–192. doi:10.3892/mmr.2018.894529749446
   PubMed Web of Science ®Google Scholar
• Elias KM, Kang S, Liu X, Horowitz NS, Berkowitz RS, Frendl G. Anesthetic selection and disease-free survival following optimal primary cytoreductive surgery for stage III epithelial ovarian cancer. Ann Surg Oncol. 2015;22(4):1341–1348. doi:10.1245/s10434-014-4112-925287437
   PubMed Web of Science ®Google Scholar
• Hurmath FK, Mittal M, Ramaswamy P, Umamaheswara Rao GS, Dalavaikodihalli Nanjaiah N. Sevoflurane and thiopental preconditioning attenuates the migration and activity of MMP-2 in U87MG glioma cells. Neurochem Int. 2016;94:32–38. doi:10.1016/j.neuint.2016.02.00326875426
   PubMed Web of Science ®Google Scholar
• Bundscherer AC, Ullrich V, Malsy M, et al. Effects of volatile anesthetics on proliferation and viability of SW480 colon cancer cells in vitro. Anticancer Res. 2019;39(11):6049–6055. doi:10.21873/anticanres.1381131704831
   PubMed Web of Science ®Google Scholar
• Cata JP, Keerty V, Keerty D, et al. A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection. Cancer Med. 2014;3(4):900–908. doi:10.1002/cam4.23624692226
   PubMed Web of Science ®Google Scholar
• Zhu J, Han S. Lidocaine inhibits cervical cancer cell proliferation and induces cell apoptosis by modulating the lncRNA-MEG3/miR-421/BTG1 pathway. Am J Transl Res. 2019;11(9):5404–5416.31632519
   PubMed Web of Science ®Google Scholar
• Wall TP, Crowley PD, Sherwin A, Foley AG, Buggy DJ. Effects of lidocaine and src inhibition on metastasis in a murine model of breast cancer surgery. Cancers (Basel). 2019;11(10):1414. doi:10.3390/cancers11101414
   PubMed Web of Science ®Google Scholar
• Sun H, Sun Y. Lidocaine inhibits proliferation and metastasis of lung cancer cell via regulation of miR-539/EGFR axis. Artif Cells Nanomed Biotechnol. 2019;47(1):2866–2874. doi:10.1080/21691401.2019.163680731299862
   PubMed Web of Science ®Google Scholar
• Dong Q, Mao Z. The local anaesthetic lignocaine exhibits potent antilung cancer cell activity by inhibiting the phosphoinositide 3-kinases/mammalian target of rapamycin/mammalian target of rapamycin pathway. Pharmacology. 2019;104(3–4):139–146. doi:10.1159/00050074331203272
   PubMed Web of Science ®Google Scholar
• Xia W, Wang L, Yu D, Mu X, Zhou X. Lidocaine inhibits the progression of retinoblastoma in vitro and in vivo by modulating the miR‑520a‑3p/EGFR axis. Mol Med Rep. 2019;20(2):1333–1342. doi:10.3892/mmr.2019.1036331173241
   PubMed Web of Science ®Google Scholar
• Ye L, Zhang Y, Chen YJ, Liu Q. Anti-tumor effects of lidocaine on human gastric cancer cells in vitro. Bratisl Lek Listy. 2019;120(3):212–217. doi:10.4149/BLL_2019_03631023040
   PubMed Web of Science ®Google Scholar
• Xing W, Chen DT, Pan JH, et al. Lidocaine induces apoptosis and suppresses tumor growth in human hepatocellular carcinoma cells in vitro and in a xenograft model in vivo. Anesthesiology. 2017;126(5):868–881. doi:10.1097/ALN.000000000000152828121635
   PubMed Web of Science ®Google Scholar
• Zhu Q, Zhu G, Xu W, Dan J, Xia R, Liu W. Bupivacaine inhibits angiogenesis through oxidative stress-dependent inhibition of Akt/mTOR and activation of AMPK. Fundam Clin Pharmacol. 2020. doi:10.1111/fcp.12554
   Web of Science ®Google Scholar
• Zhang H, Lin J, Hu T, Ren Z, Wang W, He Q. Effect of miR-132 on bupivacaine-induced neurotoxicity in human neuroblastoma cell line. J Pharmacol Sci. 2019;139(3):186–192. doi:10.1016/j.jphs.2019.01.01430850243
   PubMed Web of Science ®Google Scholar
• Xuan W, Zhao H, Hankin J, Chen L, Yao S, Ma D. Local anesthetic bupivacaine induced ovarian and prostate cancer apoptotic cell death and underlying mechanisms in vitro. Sci Rep. 2016;6:26277. doi:10.1038/srep2627727195613
   PubMed Web of Science ®Google Scholar
• Li YC, Wang Y, Li DD, Zhang Y, Zhao TC, Li CF. Procaine is a specific DNA methylation inhibitor with anti-tumor effect for human gastric cancer. J Cell Biochem. 2018;119(2):2440–2449. doi:10.1002/jcb.2640728926119
   PubMed Web of Science ®Google Scholar
• Li C, Gao S, Li X, Ma L, Ma L. Procaine inhibits the proliferation and migration of colon cancer cells through inactivation of the ERK/MAPK/FAK pathways by regulation of RhoA. Oncol Res. 2018;26(2):209–217. doi:10.3727/096504017X1494458587362228492141
   PubMed Web of Science ®Google Scholar
• Ying B, Huang H, Li H, Song M, Wu S, Ying H. Procaine inhibits proliferation and migration and promotes cell apoptosis in osteosarcoma cells by upregulation of microRNA-133b. Oncol Res. 2017;25(9):1463–1470. doi:10.3727/096504017X1487851829107728251881
   PubMed Web of Science ®Google Scholar
• Ma Y, Ren Z, Ma S, et al. Morphine enhances renal cell carcinoma aggressiveness through promotes survivin level. Ren Fail. 2017;39(1):258–264. doi:10.1080/0886022X.2016.125632227866460
   PubMed Web of Science ®Google Scholar
• Li T, Chen L, Zhao H, et al. Both Bupivacaine and Levobupivacaine inhibit colon cancer cell growth but not melanoma cells in vitro. J Anesth. 2019;33(1):17–25. doi:10.1007/s00540-018-2577-630426213
   PubMed Web of Science ®Google Scholar
• Malsy M, Graf B, Bundscherer A. The effects of analgesics and local anesthetics on gene transcription mediated by NFATc2 and Sp1 in pancreatic carcinoma. Anticancer Res. 2019;39(9):4721–4728. doi:10.21873/anticanres.1365431519571
   PubMed Web of Science ®Google Scholar
• Wang HL, Yan HD, Liu YY, et al. Intraoperative intravenous lidocaine exerts a protective effect on cell-mediated immunity in patients undergoing radical hysterectomy. Mol Med Rep. 2015;12(5):7039–7044. doi:10.3892/mmr.2015.423526299324
   PubMed Web of Science ®Google Scholar
• Piegeler T, Votta-Velis EG, Liu G, et al. Antimetastatic potential of amide-linked local anesthetics: inhibition of lung adenocarcinoma cell migration and inflammatory Src signaling independent of sodium channel blockade. Anesthesiology. 2012;117(3):548–559. doi:10.1097/ALN.0b013e318266197722846676
   PubMed Web of Science ®Google Scholar
• Li R, Xiao C, Liu H, Huang Y, Dilger JP, Lin J. Effects of local anesthetics on breast cancer cell viability and migration. BMC Cancer. 2018;18(1):666. doi:10.1186/s12885-018-4576-229914426
   PubMed Web of Science ®Google Scholar